CompletedNot applicableNCT00027443
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
Studying Idiopathic giant cell myocarditis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Leslie T Cooper, MDMayo Clinic
- Intervention
- Muromonab-CD3(drug)
- Enrollment
- 40 enrolled
- Eligibility
- All sexes
- Timeline
- 2001 – 2007
Study locations (1)
- Mayo Clinic Rochester, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00027443 on ClinicalTrials.gov